ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring
Year: 2022
Type: article
Abstract: Since publication of the 2018 guidelines, the area of glucose monitoring has evolved, especially as regards continuous glucose monitoring (CGM) systems.CGM is more widely available in many parts of the world; latest generation devices are factory-calibrated, more accurate, and do not need a confirmatory fingerstick blood glucose measurement.More studies regarding the efficacy of CGM systems, irrespective of the type of insulin delivery, are available including long-term observational studies.With increased availability and wider use, practical considerations related to daily CGM use (e.g., skin issues, physical activity) as well as educational and psychosocial aspects have come to the fore, which are also addressed in this chapter.
Source: Pediatric Diabetes
DOI: 10.1111/pedi.13451
Institutions: Medical University of Vienna, University of Colorado Anschutz, Stanford Medicine, Stanford University, Hospital Sant Joan de Déu Barcelona, Humanitas University, Deakin University, Diabetes Victoria, Baylor College of Medicine, Texas Children's Hospital, Boston Children's Hospital, Joslin Diabetes Center, Diabetes Care & Hormone Clinic, Southern District Health Board, University of Otago, Endocrinology Research Center, University of Port Harcourt Teaching Hospital, Riley Hospital for Children, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,400
OpenAlex ID: W4311973329
